Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma | NEJM

At the same time Belinda was reported and published as well. However, despite a similar design (albeit with some potentially significant differences) Tisa-Cel was not better than chemo followed by auto transplant. Was the ability to try a second salvage regimen to help get to the auto-transplant a factor? (10% of the patients transplanted had a second salvage regimen)

Read the full article here

Related Articles